Marc Salzberg

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors

Eilon D. Kirson, Vladimír Dbalý, F Tovaryś et al. · Proceedings of the National Academy of Sciences · 2007 · 846 citations · Full text

Tumor Innervation, High-grade Gliomas, Biomedical Engineering +21

Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

Stephen Chan, M. E. Scheulen, S. Johnston et al. · Journal of Clinical Oncology · 2005 · 468 citations · Full text

Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects

Manuel Haschke, Manfred Schuster, Marko Poglitsch et al. · Clinical Pharmacokinetics · 2013 · 373 citations · Full text

Hypertension, Cardiovascular Disease, Medicine +6

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen‐specific immunotherapy in patients with MUC1‐positive advanced cancer

Christoph Rochlitz, Robert A. Figlin, Patrick Squiban et al. · The Journal of Gene Medicine · 2003 · 172 citations

A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer

Miklos Pless, C. Droege, Roger von Moos et al. · Lung Cancer · 2013 · 101 citations

Tumor Treating Fields, Medicine, Bronchial Neoplasm +8